Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rigel Pharmaceuticals Inc (NASDAQ:RIGL)

3.93
Delayed Data
As of 4:00pm ET
 +1.29 / +48.86%
Today’s Change
1.88
Today|||52-Week Range
4.06
+29.70%
Year-to-Date
Markets Very Sluggish as August Nears an End
1:56pm / TheStreet.com - Paid Partner Content
Rigel Pharma (RIGL) Stock Jumps on Study Results, Piper Jaffray Ups Price Target
11:30am / TheStreet.com - Paid Partner Content
Here's Why Rigel Pharmaceuticals, Inc. is Skyrocketing Today
12:16pm / MotleyFool.com - Paid Partner Content
Rigel Pharma Claims Late-Stage Study Win for Blood Platelet Drug
7:52am / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close2.64
Today’s open3.26
Day’s range3.25 - 4.06
Volume55,750,850
Average volume (3 months)599,525
Market cap$249.7M
Dividend yield--
Data as of 4:00pm ET, 08/30/2016

Growth & Valuation

Earnings growth (last year)+44.23%
Earnings growth (this year)-28.97%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+250.24%
P/E ratioNM
Price/Sales9.27
Price/Book2.62

Competitors

 Today’s
change
Today’s
% change
IMGNImmunoGen Inc-0.02-0.69%
EDGEEdge Therapeutics In...-0.03-0.34%
RXDXIgnyta Inc-0.07-1.24%
CYADCelyad SA-1.93-7.72%
Data as of 4:00pm ET, 08/30/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$28.9M
Annual profit (last year)-$51.5M
Net profit margin-178.11%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Raul R. Rodriguez
CFO, Executive VP &
Head-Investor Relations
Ryan D. Maynard
Corporate headquarters
South San Francisco, California

Forecasts

Search for Jobs